Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Blood

Volumn 121, Issue 13, 2013, Pages 2415-2423

  Dastugue, Nicole ^a   Suciu, Stefan ^b   Plat, Geneviève ^c   Speleman, Frank ^d   Cavé, Hélène ^e,f   Girard, Sandrine ^g   Bakkus, Marleen ^h   Pagès, Marie Pierre ^g   Yakouben, Karima ^e   Nelken, Brigitte ⁱ   Uyttebroeck, Anne ^j   Gervais, Carine ^k   Lutz, Patrick ^l   Teixeira, Manuel R ^m   Heimann, Pierre ⁿ   Ferster, Alice ^o   Rohrlich, Pierre ^p   Collonge, Marie Agnès ^p   Munzer, Martine ^q   Luquet, Isabelle ^q   Boutard, Patrick ^r   Sirvent, Nicolas ^s   Karrasch, Matthias ^b   Bertrand, Yves ^t   Benoit, Yves ^d   more..

^a CHU PURPAN   (France)

^b EORTC DATA CENTER   (Belgium)

^c HÔPITAL DES ENFANTS   (France)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g CENTRE HOSPITALIER LYON SUD   (France)

^h UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

ⁱ UNIV LILLE   (France)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k Hematology Laboratory   (France)

^l Hematology Laboratory ^*  (France)

^m UNIVERSITY OF PORTO   (Portugal)

ⁿ JULES BORDET INSTITUTE   (Belgium)

^o HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^p UNIVERSITY HOSPITAL OF BESANÇON   (France)

^q REIMS UNIVERSITY HOSPITAL   (France)

^r CAEN UNIVERSITY HOSPITAL   (France)

^s UNIVERSITY HOSPITAL OF NICE   (France)

^t HOSPICES CIVILS DE LYON   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DNA; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER PROGNOSIS; CHILD; CHROMOSOME; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 4; DIPLOIDY; EUROPEAN; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERDIPLOIDY; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RESEARCH; TRISOMY; CHROMOSOME ABERRATION; CLINICAL TRIAL (TOPIC); GENETIC HETEROGENEITY; GENETICS; INFANT; KARYOTYPING; METHODOLOGY; NEWBORN; ONSET AGE; PATHOLOGY; POLYPLOIDY; PRESCHOOL CHILD; REMISSION; STATISTICS;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES; CLINICAL TRIALS AS TOPIC; DIPLOIDY; FEMALE; FOLLOW-UP STUDIES; GENETIC HETEROGENEITY; HUMANS; INFANT; INFANT, NEWBORN; KARYOTYPING; MALE; POLYPLOIDY; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REMISSION INDUCTION;

MLCS; MLOWN;

EID: 84878392379     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-437681     Document Type: Article

References (30)

1. Kaneko Y, Hayashi Y, Sakurai M. Chromosomal findings and their correlation to prognosis in acute lymphocytic leukemia. Cancer Genet Cytogenet. 1981;4(3):227-235.
2. Third International Workshop on Chromosomes in Leukemia. Chromosomal abnormalities in acute lymphoblastic leukemia: structural and numerical changes in 234 cases. Cancer Genet Cytogene. 1981;4(2):101–110.
3. Williams DL, Tsiatis A, Brodeur GM, et al. Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood. 1982;60(4):864-871.
4. Moorman AV, Richards SM, Martineau M, et al; United Kingdom Medical Research Council’s Childhood Leukemia Working Party. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood. 2003; 102(8):2756-2762.
5. Raimondi SC, Pui C-H, Hancock ML, et al. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia. 1996; 10(2):213-224.
6. Heerema NA, Raimondi SC, Anderson JR, et al. Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2007;46(7):684-693.
7. Look AT, Roberson PK, Williams DL, et al. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood. 1985;65(5):1079-1086.
8. Rachieru-Sourisseau P, Baranger L, Dastugue N, et al. DNA index in childhood acute lymphoblastic leukaemia: a karyotypic method to validate the flow cytometric measurement. Int J Lab Hematol. 2010;32(3):288-298.
9. Silverman LB, Stevenson KE, O’Brien JE, et al. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia. 2010;24(2):320-334.
10. Möricke A, Zimmermann M, Reiter A, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010;24(2):265-284.
11. Kamps WA, van der Pal-de Bruin KM, Veerman AJ, et al. Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia. 2010;24(2):309-319.
12. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26): 2730-2741.
13. Moorman AV, Ensor HM, Richards SM, et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol. 2010;11(5):429-438.
14. Harris MB, Shuster JJ, Carroll A, et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood. 1992; 79(12):3316-3324.
15. Heerema NA, Sather HN, Sensel MG, et al. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (.50 chromosomes). J Clin Oncol. 2000;18(9): 1876-1887.
16. Sutcliffe MJ, Shuster JJ, Sather HN, et al. High concordance from independent studies by the Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children’s Oncology Group (COG) initiative. Leukemia. 2005;19(5):734-740.
17. Schultz KR, Pullen DJ, Sather HN, et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG). Blood. 2007; 109(3):926-935.
18. Borowitz MJ, Devidas M, Hunger SP, et al; Children’s Oncology Group. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children’s Oncology Group study. Blood. 2008;111(12):5477-5485.
19. Pui C-H, Raimondi SC, Dodge RK, et al. Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia. Blood. 1989;73(7): 1963-1967.
20. Ramos ML, Palacios JJ, Fournier BG, et al. Prognostic value of tumoral ploidy in a series of Spanish patients with acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2000;122(2): 124-130.
21. Zemanova Z, Michalova K, Sindelarova L, et al. Prognostic value of structural chromosomal rearrangements and small cell clones with high hyperdiploidy in children with acute lymphoblastic leukemia. Leuk Res. 2005;29(3): 273-281.
22. Bene MC, Castoldi G, Knapp W, et al; European Group for the Immunological Characterization of Leukemias (EGIL). Proposals for the immunological classification of acute leukemias. Leukemia. 1995;9(10): 1783-1786.
23. Guidal C, Vilmer E, Grandchamp B, et al. A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia. Leukemia. 2002; 16(4):762-764.
24. De Moerloose B, Suciu S, Bertrand Y, et al; Children’s Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC). Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. Blood. 2010; 116(1):36-44.
25. Vindeløv LL, Christensen IJ. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry. 1990; 11(7):753-770.
26. Kalbfleisch JD, Prentice RL. The Survival Analysis of Failure Time Data. 2nd ed. Hoboken, NJ: Wiley Inter-Science; 2002.
27. Paulsson K, Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2009;48(8): 637-660.
28. Charrin C, Thomas X, Ffrench M, et al. A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL). Blood. 2004; 104(8):2444-2451.
29. Duval M, Suciu S, Ferster A, et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer—Children’s Leukemia Group phase 3 trial. Blood. 2002;99(8):2734-2739.
30. van der Werff Ten Bosch J, Suciu S, Thyss A, et al. Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin’s lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Leukemia. 2005; 19(5):721-726.